Vyome Holdings, Inc. ("Vyome") announced the final results from an investigator-initiated Phase 2 proof of concept study of VT-1953 topical gel in people with malignant fungating wounds ("MFW").

Sensitive tests designed to detect very small numbers of remaining leukemia cells after treatment, known as measurable ...

In a large analysis presented at ASH's annual meeting, researchers reported that patients' MRD status after intensive chemo can predict their survival.

Emerging tests and treatment strategies guide more tailored approaches and ease the burden on patientsORLANDO, Fla., Dec. 6, ...

Sensitive tests designed to detect very small numbers of remaining leukemia cells after treatment, known as measurable residual disease (MRD), may provide an early and reliable indicator of long-term ...

If you're looking to adopt a zero trust platform in 2025, these solutions streamline remote access, enhance user authentication, and protect complex IT systems.

Join Chris Ritchhart of Check Point and Teresa Cortez of Insight for a lively, fast-paced session as they explore how Harmony SASE, Harmony Browse (with gen AI protection), and Harmony Mobile work ...

With global security spending continuing to rise, these cybersecurity stocks are worth a closer look.

CheckPoint Software Technologies offers a comprehensive suite of cybersecurity products including network security, endpoint security, cloud security, and threat prevention solutions, with key ...

UniQure shares were halted at $14.09 in premarket trading after the company reported positive topline results for Phase I/II study of AMT-130 for the treatment of Huntington's disease. The gene ...

Camila Cabello, Normani, Ally Brooke, Dinah Jane and Lauren Jauregui created Fifth Harmony in 2012 Caroline Blair is a writer for PEOPLE. She has been writing about celebrities, entertainment, reality ...